| For: | Ayoub F, Trillo-Alvarez C, Morelli G, Lascano J. Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease. World J Hepatol 2018; 10(1): 34-40 [PMID: 29399276 DOI: 10.4254/wjh.v10.i1.34] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v10/i1/34.htm |
| Number | Citing Articles |
| 1 |
Katja Glutig, Paul-Christian Krüger, Theresa Oberreuther, Ulf Teichgräber, Michael Lorenz, Hans-Joachim Mentzel, Martin Krämer. A novel free-breathing abdominal RAVE T2/T1 hybrid MRI sequence in patients with cystic fibrosis: Preliminary results. European Journal of Radiology 2022; 154 doi: 10.1016/j.ejrad.2022.110454
|
| 2 |
Anna Bertolini, Frank A. J. A. Bodewes, Mordechai Slae, Michael Wilschanski. Cystic Fibrosis. Respiratory Medicine 2020; doi: 10.1007/978-3-030-42382-7_14
|
| 3 |
Rosara Bass, Jessica A. Alvarez. Nutritional status in the era of highly effective CFTR modulators. Pediatric Pulmonology 2024; 59(S1) doi: 10.1002/ppul.26806
|
| 4 |
Jessica M. Shape, Marc A. Sala. Nutrition management in adults with cystic fibrosis. Nutrition in Clinical Practice 2022; 37(2) doi: 10.1002/ncp.10842
|
| 5 |
Lenycia de Cassya Lopes Neri, Miriam Isabel Souza dos Santos Simon, Valéria Laguna Salomão Ambrósio, Eliana Barbosa, Monique Ferreira Garcia, Juliana Ferreira Mauri, Renata Rodrigues Guirau, Mirella Aparecida Neves, Carolina de Azevedo Pedrosa Cunha, Marcelo Coelho Nogueira, Anna Carolina Di Creddo Alves, Jocemara Gurmini, Maria de Fatima Servidoni, Matias Epifanio, Rodrigo Athanazio. Brazilian Guidelines for Nutrition in Cystic Fibrosis. Einstein (São Paulo) 2022; 20 doi: 10.31744/einstein_journal/2022RW5686
|
| 6 |
Sarah Shrager Lusman, Johanna Ferreira, Benjamin Sahn. Pediatric Gastrointestinal and Liver Disease. 2026; doi: 10.1016/B978-0-443-11760-2.00082-3
|
| 7 |
Tanvi Patel, Kimberly McBennett, Senthilkumar Sankararaman, Teresa Schindler, Krithika Sundaram, Nori Mercuri Minich, Sindhoosha Malay, Katherine Kutney. Impact of elexacaftor/tezacaftor/ivacaftor on lipid and fat‐soluble vitamin levels and association with body mass index. Pediatric Pulmonology 2024; 59(3) doi: 10.1002/ppul.26823
|
| 8 |
Katherine Kutney, Shannon B Donnola, Chris A Flask, Rose Gubitosi-Klug, MaryAnn O’Riordan, Kimberly McBennett, Thomas J Sferra, Beth Kaminski. Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients. World Journal of Hepatology 2019; 11(12): 761-772 doi: 10.4254/wjh.v11.i12.761
|
| 9 |
Almudena Felipe Montiel, Antonio Álvarez Fernández, Mario Culebras Amigo, Letizia Traversi, David Clofent Alarcón, Karina Loor Reyes, Eva Polverino. The ageing of people living with cystic fibrosis: what to expect now?. European Respiratory Review 2024; 33(174) doi: 10.1183/16000617.0071-2024
|
| 10 |
Diana Coman, Marc Bilodeau, Catherine Vincent, Emmanuelle Brochiero, Annick Lavoie, Julian Hercun. Integration of Non-invasive Screening for Cystic Fibrosis Related Liver Disease in the Regular Follow-Up for Cystic Fibrosis. Digestive Diseases and Sciences 2025; 70(2) doi: 10.1007/s10620-024-08784-0
|
| 11 |
Amanda Oliva Gobato, Ana Carolina Junqueira Vasques, Antonio Fernando Ribeiro, Roberto Massao Yamada, Gabriel Hessel. PREVALENCE OF HEPATIC STEATOSIS AMONG CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS AND ITS ASSOCIATION WITH NUTRITIONAL STATUS. Revista Paulista de Pediatria 2019; 37(4) doi: 10.1590/1984-0462/;2019;37;4;00007
|
| 12 |
Amir Moheet, Kevin J. Scully, Tasma Harindhanavudhi, Samantha Steinmetz-Wood, Heidi Guzman, Lesleann Hayward Story, Melissa S. Putman. The endocrine complications of cystic fibrosis. Nature Reviews Endocrinology 2026; 22(3) doi: 10.1038/s41574-025-01196-8
|
| 13 |
Sofia Manioudaki, Larisa Vasilieva, Eleni Geladari, Iliana Mani, Vasilios Sevastianos, Filia Diamantea, Alexandra Alexopoulou. Hepatic steatosis in adults on CFTR modulators is commonly associated with cardiometabolic criteria consistent with metabolic dysfunction-associated steatotic liver disease. Journal of Cystic Fibrosis 2026; 25(5) doi: 10.1016/j.jcf.2026.06.008
|
| 14 |
Tianhao Zhou, Debjyoti Kundu, Jonathan Robles-Linares, Vik Meadows, Keisaku Sato, Leonardo Baiocchi, Burcin Ekser, Shannon Glaser, Gianfranco Alpini, Heather Francis, Lindsey Kennedy. Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease. Cells 2021; 10(8) doi: 10.3390/cells10082072
|
| 15 |
Sabina Wiecek. Cystic Fibrosis - Heterogeneity and Personalized Treatment. 2020; doi: 10.5772/intechopen.89306
|
| 16 |
Saioa Vicente-Santamaría, Ana Tabares-González, Celia Gascón-Galindo, Carlos Tutau-Gómez, Marina Álvarez-Beltrán, Rosa Ana Muñoz-Codoceo, María Rubio-Murillo, Marianela De-Los-Santos, Enrique Salcedo-Lobato, Etna Masip-Simó, Ruth García-Romero, Ana Estefanía Fernández-Lorenzo, Ana Moreno-Álvarez, Juliana Serrano-Nieto, Loreto Hierro-Llanillo, Inés Loverdos-Eseverri, Elena Crehuá-Gaudiza, Mercedes Juste-Ruiz, Enrique Blitz-Castro, Ana Morales-Tirado, Concepción Marina López-Cárdenes, Carlos Bousoño-García, David González-Jiménez. Current situation of pediatric cystic fibrosis-related liver disease: results of a Spanish nationwide study. European Journal of Gastroenterology & Hepatology 2025; 37(4) doi: 10.1097/MEG.0000000000002917
|
| 17 |
Nicole Green, Daniel H. Leung. Cystic Fibrosis-Associated Hepatobiliary Involvement. Clinics in Liver Disease 2026; doi: 10.1016/j.cld.2026.07.008
|
| 18 |
Fares Ayoub, Hechu Li, Charles Blay, Cesar Trillo‐Alvarez, Jorge Lascano, Giuseppe Morelli. Multidisciplinary Care for Cystic Fibrosis Liver Disease: Where Does the Adult Hepatologist Fit In?. Clinical Liver Disease 2019; 14(5) doi: 10.1002/cld.845
|
| 19 |
Katherine A. Kutney, Zahrae Sandouk, Marisa Desimone, Amir Moheet. Obesity in cystic fibrosis. Journal of Clinical & Translational Endocrinology 2021; 26 doi: 10.1016/j.jcte.2021.100276
|
| 20 |
Ana Piñar-Gutiérrez, Esther Quintana-Gallego, Pablo J. Remón-Ruiz, Ángeles Pizarro, Irene González-Navarro, Andrés Jiménez-Sánchez, Silvia García-Rey, María del Carmen Roque-Cuéllar, Sheila Gato, Inmaculada Domínguez, Francisco Javier Castell, Manuel Romero-Gómez, Pedro Pablo García-Luna. Non-invasive evaluation of steatosis and fibrosis in the liver in adults patients living with cystic fibrosis. Journal of Cystic Fibrosis 2025; 24(3) doi: 10.1016/j.jcf.2025.02.007
|
| 21 |
Anan A. Abu Rmilah, Wei Zhou, Scott L. Nyberg. Hormonal Contribution to Liver Regeneration. Mayo Clinic Proceedings: Innovations, Quality & Outcomes 2020; 4(3) doi: 10.1016/j.mayocpiqo.2020.02.001
|
| 22 |
Sabina Więcek, Halina Woś, Andrzej Pogorzelski, Bożena Kordys-Darmolinska, Henryk Mazurek, Urszula Grzybowska-Chlebowczyk. Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis. Mediators of Inflammation 2020; 2020 doi: 10.1155/2020/5696185
|
| 23 |
Xingxing Chen, Liying Fu, Zhongxin Zhu, Yunchao Wang. Exploring the link: magnesium intake and hepatic steatosis in Americans. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1367174
|
| 24 |
A. Jay Freeman, Frank A.J.A. Bodewes. An update on cystic fibrosis Hepato-biliary involvement. Journal of Cystic Fibrosis 2026; 25(3) doi: 10.1016/j.jcf.2026.03.022
|
| 25 |
Thomas Boat, Elizabeth Hente, William Hardie, Rhonda Szczesniak, Emrah Gecili, Grace Zhou, Jacqueline Taylor, Raouf Amin. Body composition and functional correlates of CF youth experiencing pulmonary exacerbation and recovery. Pediatric Pulmonology 2023; 58(2) doi: 10.1002/ppul.26207
|
| 26 |
Tasma Harindhanavudhi, Monica E. Bianco, Nellie S. Hani, Amir Moheet. Obesity and Metabolic Complications in Cystic Fibrosis. Endocrine Practice 2026; 32(8) doi: 10.1016/j.eprac.2026.03.099
|
| 27 |
Maya Mahmoud, Eugene Nwankwo, Zidong Zhang, Neel Matiwala, Rohan Tripathi, Islam Mohamed, Christopher Barrios, Wing-Kin Syn, Christine Hachem. Low prevalence of peptic ulcer disease in hospitalized patients with cystic fibrosis: A national database study. The American Journal of the Medical Sciences 2025; 369(3) doi: 10.1016/j.amjms.2024.09.001
|
| 28 |
Johann Colomba, Silvia R. Netedu, Catherine Lehoux-Dubois, Adèle Coriati, Valérie Boudreau, François Tremblay, Kenneth Cusi, Rémi Rabasa-Lhoret, Julio A. Leey, Wenjun Ding. Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis. PLOS ONE 2019; 14(7) doi: 10.1371/journal.pone.0219855
|
| 29 |
Almudena Marinero Martínez-Lázaro, Rosa María Girón Moreno, Fernando Casals Seoane, Óscar Cano-Valderrama, Luisa García-Buey. Cystic fibrosis with liver involvement in adults has a benign course. Results from a tertiary referral centre cohort. Revista Española de Enfermedades Digestivas 2022; 114 doi: 10.17235/reed.2022.9289/2022
|
| 30 |
Zahra Namkhah, Fatemeh Naeini, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh‐Attar. The association of the adipokine zinc‐alpha2‐glycoprotein with non‐alcoholic fatty liver disease and related risk factors: A comprehensive systematic review. International Journal of Clinical Practice 2021; 75(7) doi: 10.1111/ijcp.13985
|
| 31 |
Heather Girouard, Farah Jaber, Josh Gharib, Valérie Boudreau, Laure Alexandre-Heymann, Adèle Coriati. The impact of elexacaftor–tezacaftor–ivacaftor on cardiometabolic risk factors: a systematic review. European Respiratory Review 2026; 35(179) doi: 10.1183/16000617.0197-2025
|
| 32 |
|
| 33 |
Zaina Issa, Sophie Gohy, Francis Zech, Pamela Baldin, Bénédicte Delire, Géraldine Dahlqvist. Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis. Clinics and Research in Hepatology and Gastroenterology 2022; 46(9) doi: 10.1016/j.clinre.2022.101977
|
| 34 |
Zachary M. Sellers, David N. Assis, Shruti M. Paranjape, Meghana Sathe, Frank Bodewes, Melissa Bowen, Marco Cipolli, Dominique Debray, Nicole Green, Kara S. Hughan, William R. Hunt, Julio Leey, Simon C. Ling, Giuseppe Morelli, Daniel Peckham, Rebeca S. Pettit, Alexander Philbrick, Janis Stoll, Kay Vavrina, Stacy Allen, Tara Goodwin, Sarah E. Hempstead, Michael R. Narkewicz. Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations. Hepatology 2024; 79(5) doi: 10.1097/HEP.0000000000000646
|
| 35 |
Sabina Wiecek, Piotr Fabrowicz, Halina Wos, Bożena Kordys-Darmolinska, Maciej Cebula, Katarzyna Gruszczynska, Urszula Grzybowska-Chlebowczyk, Zhengwen Liu. Assessment of Liver Fibrosis with the Use of Elastography in Paediatric Patients with Diagnosed Cystic Fibrosis. Disease Markers 2022; 2022 doi: 10.1155/2022/4798136
|
| 36 |
Lucile Regard, Clémence Martin, Guillaume Chassagnon, Pierre-Régis Burgel. Acute and chronic non-pulmonary complications in adults with cystic fibrosis. Expert Review of Respiratory Medicine 2019; 13(1) doi: 10.1080/17476348.2019.1552832
|
| 37 |
Jordan S. Sherwood, Jagdeesh Ullal, Katherine Kutney, Kara S. Hughan. Cystic fibrosis related liver disease and endocrine considerations. Journal of Clinical & Translational Endocrinology 2022; 27 doi: 10.1016/j.jcte.2021.100283
|
| 38 |
Ki-Kwang Oh, Haripriya Gupta, Raja Ganesan, Satya Priya Sharma, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Byeong-Hyun Min, Ji-Ye Hyun, Jung-A Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Dong Joon Kim, Ki-Tae Suk. The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysis. Artificial Cells, Nanomedicine, and Biotechnology 2023; 51(1) doi: 10.1080/21691401.2023.2203734
|
| 39 |
L. Regard, H. Lafoeste, C. Martin, G. Chassagnon, P.-R. Burgel. Vieillir avec la mucoviscidose : comorbidités classiques et émergentes chez l’adulte mucoviscidosique. Revue de Pneumologie Clinique 2018; 74(5) doi: 10.1016/j.pneumo.2018.09.012
|
| 40 |
Alexander J. Towbin, Wen Ye, Suiyuan Huang, Boaz W. Karmazyn, Jean P. Molleston, Prakash Masand, Daniel H. Leung, Samuel Chang, Michael R. Narkewicz, Adina L. Alazraki, A. Jay Freeman, Randolph K. Otto, Nicole Green, Ihab R. Kamel, Wikrom W. Karnsakul, John C. Magee, Jean Tkach, Joseph J. Palermo. Prospective study of quantitative liver MRI in cystic fibrosis: feasibility and comparison to PUSH cohort ultrasound. Pediatric Radiology 2023; 53(11) doi: 10.1007/s00247-023-05706-6
|